Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Income from Non-Controlling Interests (2021 - 2024)

Historic Income from Non-Controlling Interests for Agilon Health (AGL) over the last 4 years, with Q2 2024 value amounting to $20000.0.

  • Agilon Health's Income from Non-Controlling Interests rose 14347.83% to $20000.0 in Q2 2024 from the same period last year, while for Mar 2025 it was $20000.0, marking a year-over-year increase of 11754.39%. This contributed to the annual value of $50000.0 for FY2024, which is 12415.46% up from last year.
  • According to the latest figures from Q2 2024, Agilon Health's Income from Non-Controlling Interests is $20000.0, which was up 14347.83% from $30000.0 recorded in Q1 2024.
  • Agilon Health's 5-year Income from Non-Controlling Interests high stood at $115000.0 for Q3 2021, and its period low was -$584000.0 during Q4 2021.
  • Over the past 4 years, Agilon Health's median Income from Non-Controlling Interests value was -$49000.0 (recorded in 2023), while the average stood at -$54571.4.
  • Over the last 5 years, Agilon Health's Income from Non-Controlling Interests had its largest YoY gain of 20273.97% in 2022, and its largest YoY loss of 18541.67% in 2022.
  • Quarter analysis of 4 years shows Agilon Health's Income from Non-Controlling Interests stood at -$584000.0 in 2021, then soared by 85.79% to -$83000.0 in 2022, then skyrocketed by 38.55% to -$51000.0 in 2023, then skyrocketed by 139.22% to $20000.0 in 2024.
  • Its last three reported values are $20000.0 in Q2 2024, $30000.0 for Q1 2024, and -$51000.0 during Q4 2023.